ST-219

N/A

Report date: 2025/01/26 16:49:57

Base Information

Drug NameST-219
Drug Alias NameST219-mAbanti Nectin-4 mAb (Stromatis Pharma)ST-219
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNectin-4 inhibitors
TargetsNectin-4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStromatis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesStromatis Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A